ArticleExploration of targeted anti-tumor therapy2023

Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma.

Celia Lara-Morga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.